Malignant mixed Müllerian tumor of the fallopian tube: a case report

Malignant mixed Mullerian tumor (MMMT) of the female genital tract is uncommon and extremely rare in the Fallopian tube. We describe a case of primary MMMT of the Fallopian tube with carcinomatous and heterologous mesenchymal components in a 60-year-old woman. The patient underwent total abdominal hysterectomy, bilateral salpingo-oophorectomy, infracolic omentectomy, pelvic and paraaortic lymph node dissection, and resection of intrapelvic metastases. The tumor formed a large polypoid mass within the right Fallopian tube and had penetrated the wall to the paraovarian space. Microscopic examination revealed two components of poorly differentiated adenocarcinoma and high-grade sarcoma with chondromatous differentiation. The patient received six courses of adjuvant chemotherapy with ifomide and cisplatin and is currently in remission. Although MMMT in the Fallopian tube shows poor prognosis, primary cytoreductive surgery with platinum-based combination chemotherapy may improve survival.

[1] Schink J.C., Lurain J.R.: “Rare gynecologic malignancies”. Curr. Opin. Obstet. Gynecol., 1991, 3, 78.

[2] Schneider C., Wight E., Perucchini D., Haller U., Fink D.: “Primary carcinoma of the fallopian tube. A report of 19 cases with literature review”. Eur. J. Gynaecol Oncol., 2000, 21, 578.

[3] Maitra R.N., Lee J., McConnell D.T., Kenwright D.N., Dady P.: “Malignant mixed mullerian tumour of the fallopian tube occurring in a patient with Peutz-Jegher’s syndrome”. Aust. N.Z.J. Obstet. Gynaecol., 2004, 44, 77.

[4] Kuroda N., Moriki T., Oguri H., Maeda N., Toi M., Miyazaki E. et al.: “Malignant müllerian mixed tumor (carcinosarcoma) of the fallopian tube: an immunohistochemical study of neoplastic cells”. APMIS, 2005, 113, 643.

[5] Costa M.J., Guinee D. Jr.: “CD34 immunohistochemistry in female genital tract carcinosarcoma (malignant mixed müllerian tumors) supports a dominant role of the carcinomatous component”. Appl. Immunohistochem. Mol. Morphol., 2000, 8, 293.

[6] Hu C.Y., Taymor M.L., Hertig A.T.: “Primary carcinoma of the fallopian tube”. Am. J. Obstet. Gynecol., 1950, 59, 58.

[7] Sedilis A.: “Primary carcinoma of the fallopian tube”. Obstet. Gynecol. Surv., 1961, 16, 209.

[8] Hanjani P., Petersen R.O., Bonnell S.A.: “Malignant mixed Mullerian tumor of the fallopian tube. Report of a case and review of literature”. Gynecol. Oncol., 1980, 9, 381.

[9] Imachi M., Tsukamoto N., Shigematsu T., Vatanabe T., Uehira K., Amada S. et al.: “Malignant mixed Müllerian tumor of the fallopian tube: report of two cases and review of literature”. Gynecol. Oncol., 1992, 47, 114.

[10] Kinoshita M., Asano S., Yamashita M., Matsuda T.: “Mesodermal mixed tumor primary in the fallopian tube”. Gynecol. Oncol., 1989, 32, 331.

[11] Baekelandt M., Jorunn Nesbakken A., Kristensen G.B., Tropé C.G., Abeler V.M.: “Carcinoma of the fallopian tube”. Cancer, 2000, 89, 2076.

[12] Muntz H.G., Rutgers J.L., Tarraza H.M., Fuller A.F. Jr.: “Carcinosarcomas and mixed Müllerian tumors of the fallopian tube”. Gynecol. Oncol., 1989, 34, 109.

[13] Sutton G., Kauderer J., Carson L.F., Lentz S.S., Whitney C.W., Gallion H., Gynecologic Oncology Group: “Adjuvant ifosfamide and cisplatin in patients with completely resected Stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study”. Gynecol. Oncol., 2005, 96, 630.

[14] Toyoshima M., Akahira J., Matsunaga G., Niikura H., Ito K., Yaegashi N., Tase T.: “Clinical experience with combination paclitaxel and carboplatin therapy for advanced or recurrent carcinosarcoma of the uterus”. Gynecol. Oncol., 2004, 94, 774.

[15] Bitterman P., Chun B., Kurman R.J.: “The significance of epithelial differentiation in mixed mesodermal tumors of the uterus. A clinicopathologic and immunohistochemical study”. Am. J. Surg. Pathol., 1990, 14, 317.

[16] Wada H., Enomoto T., Fujita M., Yoshino K. et al.: “Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors”. Cancer Res., 1997, 57, 5379.

[17] Kounelis S., Jones M.W., Papadaki H., Bakker A., Swalsky P., Finkelstein S.D.: “Carcinosarcomas (malignant mixed mullerian tumors) of the female genital tract: comparative molecular analysis of epithelial and mesenchymal components”. Hum. Pathol., 1998, 29, 82.

[18] Fujii H., Yoshida M., Gong Z.X., Matzumoto T., Hamano Y., Fukunaga M. et al.: “Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity”. Cancer Res., 2000, 60, 114.

[19] Silverberg S.G., Major F.J., Blessing J.A., Fetter B., Askin F.B., Liao S.Y. Miller A. et al.: “Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases”. Int. J. Gynecol. Pathol., 1990, 9, 1.